USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14181056

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of Basic Prolin-rich Lacrimal protein (BPLP) gene products, such as Opiorphin, for establishing a prognosis, a diagnosis or the monitoring of a pathological state or of treatment efficacy in a subject and the related method of use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT PASTEUR25-28 RUE DU DOCTEUR ROUX PARIS 75015

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dufour, Evelyne Vanves, FR 6 12
Jouannet, Pierre Paris, FR 2 0
ROUGEOT, Catherine Chevreuse, FR 28 129
Ungeheuer, Marie-Noelle Maurepas, FR 8 12
Villard-Saussine, Sylvie Issy-Les-Moulineaux, FR 9 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation